Time interval to biochemical failure as a surrogate end point in locally advanced prostate cancer: A

Just run across this on my MD Linx site

Larry

---

Male 62 DX @ 60
Dad had PC
2002. Psa. .08
2014. Psa. 3.8
2016. Psa. 19
3-08-17 RP Mayo, Mn
Gleason 9, pt3b, SV + 1 nerve, N-Margins 35 LN removed clear
Prostrate 45 grams
4-20-17 Incarcerated Umbilical Hernia
6-13-17 psa 0.13
7-19-17 psa 0.12 3TMRI with coil - clear
10-11-17 psa 0.16
10-12-17 Lupron
12-13-17 psa <0.10
12-18-17 SRT
2-7-18 SRT done 72gy
4-25-18 psa <0.10
10-29-18 psa <0.10

http://ascopubs.org/doi/abs/10.1200/JCO.18.00154?af=R&

Cut and paste for browser - would not copy as a hyperlink.

---

Husband’s info: Dx July 2018. 6 of 12 cores positive - 3 cores 4+3 and 3 cores 4+4. PSA 5.7 2/18, 6.2 5/18 RALP 8/29/18. 9/27/18. Path report: G9 4+5 pT3b, N1. EPE+, SVI +, pos margin left bladder neck, lymph nodes 1/9 positive, prostate 48g, prostate involvement 35%
12/18/18 Axumin PET scan - negative
12/19/18 Casodex; 1/2/19 Eligard
9/27/18 1st post-op PSA 0.06; 12/6 0.06; 1/2/19 <0.04

http://ascopubs.org/doi/abs/10.1200/jco.18.00154?af=r&

---

age - 63
12/09 - PSA 6.8
G7 - 3+4 - all 12 cores pos
HT, BT, IGRT
6/18 - 8-year post treatment PSA .1!
PSAs .2, .3, .2, .3, .2, .1, .2, .2, .1, .1, .1, .1, .1

/instagram.com/edraderphotography/